drugset / Trial / NCT02557490

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

NCT02557490

Phase 4 Unknown 100 enrolled Zhu Xu
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was a randomized controlled trial to compare the effect of oxaliplatin and raltitrexed treatment of colorectal cancer with liver metastases by TACE hepatic artery infusion

Timeline

Start
2015-01
Primary completion
2016-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule 130 mg/m2 Other
Subject Raltitrexed Small molecule 3 mg/m2 Other